Basic Information

Gene symbol MIR155 Synonyms MIRN155, miRNA155, mir-155 Type of gene ncRNA
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description microRNA 155

GTO ID GTC1558
Trial ID NCT02580552
Disease Mycosis Fungoides | T-Cell Lymphoma | Chronic Lymphocytic Leukemia | Large B-Cell Lymphoma
Altered gene MIR155
Therapeutic/Target gene Target gene
TherapyOligonucleotide
Treatment Cobomarsen|MRG-106
PhasePhase1
Recruitment statusCompleted
TitleA Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Year2016
CountryUnited States
Company sponsormiRagen Therapeutics, Inc.
Other ID(s)MRG106-11-101

Clinical Result

Cohort1: MF_Intratumoral Injection
Administration route intratumoral injection
Age Adult, Older_Adult
Cohort2: MF_Subcutaneous, intravenous or a combination of systemic and intratumoral administration
Administration route subcutaneous, intravenous or a combination of systemic and intratumora
Age Adult, Older_Adult
Cohort3: MF_Subcutaneous or intravenous administration
Administration route subcutaneous or intravenous administration
Age Adult, Older_Adult
Cohort4: CLL
Administration route subcutaneous or intravenous administration
Age Adult, Older_Adult
Cohort5: DLBCL
Administration route subcutaneous or intravenous administration
Age Adult, Older_Adult
Cohort6: ATLL
Administration route subcutaneous or intravenous administration
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph